
Ligand Pharmaceuticals, Inc. Share · US53220K2151 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Ligand Pharmaceuticals, Inc.
No Price
Closing Price OTC 14.04.2026:
0,002 USD
14.04.2026 18:23
Current Prices from Ligand Pharmaceuticals, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
LGNDZ
|
USD
|
14.04.2026 18:23
|
0,002 USD
| - |
Company Profile for Ligand Pharmaceuticals, Inc. Share
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Company Data
Name Ligand Pharmaceuticals, Inc.
Company Ligand Pharmaceuticals, Inc.
Website
https://www.ligand.com
Primary Exchange
UTC
ISIN US53220K2151
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Todd C. Davis
Country United States of America
Currency USD
Employees 0,1 T
Address 555 Heritage Drive, Jupiter
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | LGNDZ |
More Shares
Investors who hold Ligand Pharmaceuticals, Inc. also have the following shares in their portfolio:
